IrsiCaixa AIDS Research Institute, Barcelona, Spain
Ruth Peña
IrsiCaixa AIDS Research Institute, Barcelona, Spain
Adam Pelletier
Pathology Department, Case Western Reserve University, Cleveland, United States
Aarthi Talla
Pathology Department, Case Western Reserve University, Cleveland, United States
Ashish Sharma
Pathology Department, Case Western Reserve University, Cleveland, United States
Judith Dalmau
IrsiCaixa AIDS Research Institute, Barcelona, Spain
José Ramón Santos
Lluita contra la SIDA Foundation, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain; Infectious Diseases Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
Rafick-Pierre Sékaly
Pathology Department, Case Western Reserve University, Cleveland, United States
Bonaventura Clotet
IrsiCaixa AIDS Research Institute, Barcelona, Spain; Lluita contra la SIDA Foundation, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain; Infectious Diseases Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain; Faculty of Medicine, University of Vic - Central University of Catalonia (UVic-UCC), Catalonia, Spain
IrsiCaixa AIDS Research Institute, Barcelona, Spain; Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain; CIBER Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
The co-expression of inhibitory receptors (IRs) is a hallmark of CD8+ T-cell exhaustion (Tex) in people living with HIV-1 (PLWH). Understanding alterations of IRs expression in PLWH on long-term antiretroviral treatment (ART) remains elusive but is critical to overcoming CD8+ Tex and designing novel HIV-1 cure immunotherapies. To address this, we combine high-dimensional supervised and unsupervised analysis of IRs concomitant with functional markers across the CD8+ T-cell landscape on 24 PLWH over a decade on ART. We define irreversible alterations of IRs co-expression patterns in CD8+ T cells not mitigated by ART and identify negative associations between the frequency of TIGIT+ and TIGIT+ TIM-3+ and CD4+ T-cell levels. Moreover, changes in total, SEB-activated, and HIV-1-specific CD8+ T cells delineate a complex reshaping of memory and effector-like cellular clusters on ART. Indeed, we identify a selective reduction of HIV-1 specific-CD8+ T-cell memory-like clusters sharing TIGIT expression and low CD107a that can be recovered by mAb TIGIT blockade independently of IFNγ and IL-2. Collectively, these data characterize with unprecedented detail the patterns of IRs expression and functions across the CD8+ T-cell landscape and indicate the potential of TIGIT as a target for Tex precision immunotherapies in PLWH at all ART stages.